Education
About Us
Working with TipRanks
Follow Us
Theralase Technologies (TSE:TLT)
:TLT
TLT Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.16 - C$0.38
Previous CloseN/A
Volume127.37K
Average Volume (3M)80.03K
Market Cap
C$50.16M
Enterprise ValueC$50.30M
Total Cash (Recent Filing)C$131.76K
Total Debt (Recent Filing)C$269.58K
Price to Earnings (P/E)―
Beta>-0.01
Next Earnings
Sep 01, 2025EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding250,810,200
10 Day Avg. Volume54,435
30 Day Avg. Volume80,030
Financial Highlights & Ratios
PEG Ratio5.03
Price to Book (P/B)45.46
Price to Sales (P/S)0.00
P/FCF Ratio-18.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Theralase Technologies News
PremiumCompany Announcements
Theralase Technologies Extends Warrant Expiry to 2028
PremiumCompany Announcements
Theralase Completes $CAN 571,000 Private Placement to Advance Cancer Research
PremiumCompany Announcements
Theralase Completes Annual Meeting, Outlines Future Goals
PremiumCompany Announcements
Theralase Technologies: Navigating Growth Amid Financial Challenges
PremiumCompany Announcements
Theralase Technologies to Host Annual General Meeting with Virtual Engagement
PremiumCompany Announcements
Theralase Reports Q1 2025 Financial Results Amid Ongoing Research ProgressPremiumCompany Announcements
Theralase to Unveil Promising Cancer Treatment Research at ASTRO 2025PremiumCompany Announcements
Theralase Unveils Promising Cancer Treatment Results with RutherrinOptions Prices
Currently, No data available
---
Ownership Overview
6.25% Insiders
―
Mutual Funds
0.04% Other Institutional Investors
93.70% Public Companies and
Individual Investors
TLT FAQ
What was Theralase Technologies’s price range in the past 12 months?
Theralase Technologies lowest stock price was C$0.15 and its highest was C$0.38 in the past 12 months.
What is Theralase Technologies’s market cap?
Theralase Technologies’s market cap is C$50.16M.
When is Theralase Technologies’s upcoming earnings report date?
Theralase Technologies’s upcoming earnings report date is Sep 01, 2025 which is in 39 days.
How were Theralase Technologies’s earnings last quarter?
Theralase Technologies released its earnings results on May 29, 2025. The company reported -C$0.006 earnings per share for the quarter, missing the consensus estimate of -C$0.003 by -C$0.003.
Is Theralase Technologies overvalued?
According to Wall Street analysts Theralase Technologies’s price is currently Overvalued.
Does Theralase Technologies pay dividends?
Theralase Technologies does not currently pay dividends.
What is Theralase Technologies’s EPS estimate?
Theralase Technologies’s EPS estimate is >-0.01.
How many shares outstanding does Theralase Technologies have?
Theralase Technologies has 250,810,200 shares outstanding.
What happened to Theralase Technologies’s price movement after its last earnings report?
Theralase Technologies reported an EPS of -C$0.006 in its last earnings report, missing expectations of -C$0.003. Following the earnings report the stock price went down -4.762%.
Which hedge fund is a major shareholder of Theralase Technologies?
Currently, no hedge funds are holding shares in TSE:TLT
Theralase Technologies Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Insider Transactions
Bought Shares
Worth C$154.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
21.21%
12-Months-Change
Fundamentals
Return on Equity
-291.48%
Trailing 12-Months
Asset Growth
-8.84%
Trailing 12-Months
Company Description
Theralase Technologies
Theralase Technologies Inc. is a Canadian company operating in the biotechnology and medical device sectors. The company specializes in the design, development, and manufacturing of laser-based technologies aimed at providing advanced therapeutic solutions. Its core products include laser systems used in the treatment of pain and inflammation as well as in the destruction of cancer cells. Theralase's innovative technologies are utilized in various healthcare settings, offering non-invasive solutions to complex medical challenges.
Technical Analysis
Cannabix Technologies
―
Therma Bright
―
Aurora Spine
―
VentriPoint Diagnostics
―
Perimeter Medical Imaging AI
―